Latest News about NGM
Recent news which mentions NGM
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 23, 2023
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 16, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 13, 2023
From Benzinga
After Disappointing Phase 2 Data, Merck Drops Eye Disease Related Pact With NGM Biopharm
December 21, 2022
From Benzinga
Moderna To 170? Plus This Analyst Slashes PT On Funko By 50%
November 04, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 28, 2022
From Benzinga
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
October 21, 2022
From Benzinga
US Stocks Turn Lower; Dow Tumbles Over 100 Points
October 20, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 20, 2022
From Benzinga
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
October 20, 2022
From Benzinga
Nasdaq Rises Over 100 Points; Crude Oil Up 1.5%
October 20, 2022
From Benzinga
$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
October 20, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
From Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
From Benzinga
Dow Rises Over 2%; S&P 500 Up 100 Points
October 17, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 17, 2022
From Benzinga
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session
October 17, 2022
From Benzinga
Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates
October 17, 2022
From Benzinga
NGM Biopharmaceuticals, Fox Corporation And Some Other Big Stocks Moving Lower On Monday
October 17, 2022
From Benzinga
US Stocks Open Higher; Dow Surges 500 Points
October 17, 2022
From Benzinga
NGM Bio Plunges As Experimental Drug Fails To Meet Primary Goal In Age-Related Vision Loss Disorder
October 17, 2022
Tickers
NGM
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.